USPTO 2015–2025 USPTO PatentsView US Corporation

Roche Diagnostics Operations, Inc.

USPTO PatentsView assignee record - 654 granted patents across 111 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

654

Total patents granted

111

CPC technology areas

13.5

Avg claims per patent

-2%

5-year filing velocity

The verdict

Roche holds 654 US patents across 111 technology areas, rank #689 of 50,000 tracked assignees.

#689
of 50,000 US assignees by volume: Top 3%
by Innovation Score (62.0/100): 13.5
avg claims per patent: -2%
filing velocity, last 5 yrs

Portfolio overview

Roche Diagnostics Operations, Inc. has been granted 654 US utility patents between 2015 and 2025, placing Roche Diagnostics Operations, Inc. at rank #689 across all assignees tracked by PlainPatent. This portfolio spans 111 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.5 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a US Corporation, Roche Diagnostics Operations, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Roche sits between Inventec Corporation (656 patents, rank #685) and Incyte Corporation (652 patents, rank #693) - the closest US assignees by grant volume. The composite Innovation Score of 62.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 323 grants, compared with 331 in the 2015–2019 window, a -2% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Roche Diagnostics Operations, Inc.'s 13.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Roche Diagnostics Operations, Inc. against peers pursuing similar technology classes.

Inventec

656
Immersion

656
American Express…

655
TS TECH

655
psemi

654
Roche Diagnostics… ◀

654
Nederlandse Organ…

653
Hughes Network Sy…

652
Incyte

652

What this shows Roche holds 654 patents at rank #689, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Roche

By rank, the assignees closest to #689 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Roche's primary technology class.

Roche's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

62 Top 3% higher than 97% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Roche Diagnostics Operations, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	101	15.4%
2016	48	7.3%
2017	49	7.5%
2018	58	8.9%
2019	75	11.5%
2020	39	6.0%
2021	65	9.9%
2022	55	8.4%
2023	50	7.6%
2024	71	10.9%
2025	43	6.6%

Which technologies does Roche Diagnostics Operations, Inc. patent most?

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 482

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 141

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 78

B65G - TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS 73

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 58

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 57

C07K - PEPTIDES 49

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 37

G06F - ELECTRIC DIGITAL DATA PROCESSING 34

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 32

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 22

C12Y - ENZYMES 21

H04L - TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION 20

C07D - HETEROCYCLIC COMPOUNDS 16

H01J - ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS 15

Top 15 of 111 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Diversified

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#689

Across all tracked assignees

Innovation Score

62.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Roche Diagnostics Operations, Inc. hold?

Roche Diagnostics Operations, Inc. holds 654 US granted patents filed between 2015 and 2025, spanning 111 technology areas.

What is Roche Diagnostics Operations, Inc.'s Innovation Score?

Roche Diagnostics Operations, Inc. has an Innovation Score of 62.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Roche Diagnostics Operations, Inc. focus on?

Roche Diagnostics Operations, Inc.'s top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 482 patents. The company has filed patents in 111 CPC subclasses total.

Is Roche Diagnostics Operations, Inc.'s patent filing rate increasing or decreasing?

Roche Diagnostics Operations, Inc.'s recent filing velocity is -2% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Roche Diagnostics Operations, Inc.'s patents?

Roche Diagnostics Operations, Inc.'s patents average 13.5 claims each. This falls within the standard range, providing solid legal coverage.

How is the Roche Diagnostics Operations, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Roche's 654 grants land it in the top 3% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Roche ranks #689 of 50,000. Top 50 holders
Most of this portfolio concentrates in G01N - see who else leads that technology area. G01N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.